CUSTOMER SUPPORT

4DMEDICAL

News
4DMedical and contextflow logos
01 June 2026

4DMedical Expands into Europe with Agreement to Acquire Software Lung Imaging Leader contextflow

4DMedical, a global leader in advanced respiratory imaging and lung analysis software, has signed a binding agreement to acquire contextflow GmbH, a Vienna-based medical software imaging company specializing in lung cancer detection, chest CT analysis and radiology workflow solutions. The acquisition establishes 4DMedical’s on-the-ground European commercial platform, adding an experienced
READ MORE
4DMedical’s CT:VQ™ technology combines the anatomical clarity of CT with functional ventilation-perfusion mapping from routine non-contrast CT scans, giving clinicians quantitative insights into regional lung function without radiotracers.
30 March 2026

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union. 4DMedical will quickly launch commercial deployment of CT:VQ across one of the world's largest respiratory imaging markets.
READ MORE
4DMedical CT:VQ - Ventilation and Perfusion Analysis - Maximum Contrast and No Injections
20 January 2026

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will
READ MORE
4DMedical CT:VQ - Ventilation and Perfusion Analysis - Maximum Contrast and No Injections
19 December 2025

Aunt Minnie: 4DMedical inks major distribution agreement for CT:VQ™

New coverage from AuntMinnie.com: Philips will distribute 4DMedical’s CT:VQ™ across healthcare systems in the U.S. and Canada, expanding access to non-contrast CT-based ventilation and perfusion mapping.
READ MORE
CT:VQ™ Non-Contrast Lung Ventilation Perfusion
04 September 2025

4DMedical’s CT:VQ™ Receives FDA 510(k) Clearance; First-and-Only Non-Contrast VQ Imaging

4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world’s first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes;
READ MORE
Veterans holding their lungs - color-mapped with XV LVAS®
15 July 2025

New Study Underscores XV Technology’s Power to Detect Hidden Lung Disease

A major new multi-center study published in Respiratory Research (July 2025) demonstrates that 4DMedical’s X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS®) can reveal early and subtle forms of small airways disease that are often missed by standard tests like spirometry and CT scans. Researchers from Vanderbilt University, Johns Hopkins,
READ MORE
XV LVAS - XV Scanner Bronchiectasis
11 July 2025

Innovative XV Technology Shows Promise for Detailed Lung Function Assessment in Bronchiectasis Patients

A new study led by UNSW Sydney researchers demonstrates the feasibility and promise of the innovative XV Scanner™ with XV LVAS®, non-invasive imaging tools developed by 4DMedical, for assessing regional lung function in adults with bronchiectasis caused by Primary Ciliary Dyskinesia (PCD) and other conditions.
READ MORE
Olympus Announces Full Market Release of AI-Powered Emphysema Screening Program
09 June 2025

Olympus Launches Emphysema Screening Program Powered by 4DMedical, Expanding Early Diagnosis and Treatment Opportunities

A new peer-reviewed study published in Respiratory Research confirms that 4DMedical’s CT Lung Ventilation Analysis Software (CT LVAS) provides results comparable to those of the gold standard PET method, as well as two additional research techniques for assessing regional lung function. The findings demonstrate a strong association and agreement between
READ MORE
Respiratory Research CT LVAS Compares with PET
27 April 2025

CT Ventilation Imaging from 4DMedical Shown to Rival Gold Standard PET Scans

A new peer-reviewed study published in Respiratory Research confirms that 4DMedical’s CT Lung Ventilation Analysis Software (CT LVAS) provides results comparable to those of the gold standard PET method, as well as two additional research techniques for assessing regional lung function. The findings demonstrate a strong association and agreement between
READ MORE
04 April 2025

AI-Driven CT Innovations from 4DMedical Transform COPD Diagnosis and Patient Care

As COPD continues to grow as a global health burden—predicted by the World Health Organization (WHO) to become the third leading cause of death by 2030—innovative AI-driven medical imaging technologies are rapidly advancing diagnosis, staging, and treatment. In a recent Radiology Today article, "Breathing Room," writer Beth W. Orenstein explores
READ MORE

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis
CUSTOMER SUPPORT